We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRIN icon
13926
Trinity Capital Inc.
TRIN
$1.72B
$981 ﹤0.01%
74
-19,564
-100% -$245K
IRNT
13927
PUT
DELISTED
IronNet, Inc.
IRNT
$981 ﹤0.01%
4,700
-12,100
-72% -$3K
CBAT icon
13928
CALL
CBAK Energy Technology Ltd
CBAT
$64.1M
$976 ﹤0.01%
800
-60,200
-99% -$58.6K
GB
13929
PUT
DELISTED
Global Blue Group Holding
GB
$976 ﹤0.01%
+200
New +$1.06K
SES icon
13930
PUT
SES AI
SES
$223M
$976 ﹤0.01%
400
-3,200
-89% -$6.2K
NYMX
13931
CALL
DELISTED
Nymox Pharmaceutical Corp
NYMX
$969 ﹤0.01%
5,100
-7,300
-59% -$2.87K
REFR icon
13932
CALL
Research Frontiers
REFR
$15.3M
$960 ﹤0.01%
600
-1,100
-65% -$1.78K
LYEL icon
13933
CALL
Lyell Immunopharma
LYEL
$342M
$954 ﹤0.01%
15
-35
-70% -$1.94K
BMRA icon
13934
CALL
Biomerica
BMRA
$4.88M
$952 ﹤0.01%
88
CTXR icon
13935
Citius Pharmaceuticals
CTXR
$20.7M
$944 ﹤0.01%
31
-3,461
-99% -$114K
CHEAW
13936
DELISTED
Chenghe Acquisition Co. Warrant
CHEAW
$939 ﹤0.01%
+18,383
New +$790
HGTY icon
13937
PUT
Hagerty
HGTY
$1.32B
$936 ﹤0.01%
100
NMTR
13938
DELISTED
9 Meters Biopharma
NMTR
$933 ﹤0.01%
1,388
FNUC
13939
PUT
Frontier Nuclear and Minerals Inc
FNUC
$47.9M
$920 ﹤0.01%
31
-469
-94% -$14.8K
FTFT icon
13940
PUT
Future FinTech Group
FTFT
$1.54M
$910 ﹤0.01%
4
CIB icon
13941
Grupo Cibest SA
CIB
$22.8B
$907 ﹤0.01%
34
-108,246
-100% -$2.82M
SLVRW
13942
DELISTED
SilverSPAC Inc. Warrant
SLVRW
$906 ﹤0.01%
13,344
+43
+0.3% +$6
AEAEW
13943
DELISTED
AltEnergy Acquisition Corp Warrant
AEAEW
$903 ﹤0.01%
+25,788
New +$1.69K
EQ icon
13944
PUT
Equillium
EQ
$149M
$900 ﹤0.01%
+1,200
New +$794
GLBS icon
13945
PUT
Globus Maritime Ltd
GLBS
$78.6M
$900 ﹤0.01%
1,000
-14,500
-94% -$14.1K
AIOT
13946
PUT
PowerFleet Inc
AIOT
$417M
$900 ﹤0.01%
300
OWLT icon
13947
CALL
Owlet
OWLT
$194M
$884 ﹤0.01%
186
-1,400
-88% -$5.76K
FNVTW
13948
DELISTED
Finnovate Acquisition Corp. Warrants
FNVTW
$884 ﹤0.01%
+25,256
New +$1.08K
AKBA icon
13949
Akebia Therapeutics
AKBA
$242M
$883 ﹤0.01%
+965
New +$931
NCTY
13950
PUT
The9 Ltd
NCTY
$70M
$881 ﹤0.01%
120
-20
-14% -$162

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.